Welltower Inc.’s WELL senior housing operating (SHO) portfolio is well-poised to benefit from an aging population and a rise in healthcare expenditure by senior citizens. Moreover, favorable outpatient visit trends in the outpatient medical (OM) portfolio bode well for long-term growth. However, competition in the senior housing market poses a key concern.
What’s Aiding Welltower?
The senior citizen population is expected to rise in the coming years. This age cohort constitutes a major customer base of healthcare services and incurs higher healthcare expenditures than the average population, positioning Welltower’s SHO portfolio well to capitalize on this positive trend. In 2025, management anticipates the SHO same-store net operating income (SSNOI) to grow within 18.5-21.5%, driven by same-store revenue growth of 9.2%, occupancy rise of 360 basis points and expense increase of 5.25%.
Historically, there has been a favorable outpatient visit trend compared with inpatient admissions. Banking on this, the company is optimizing its OM portfolio and growing relationships with health system partners and deploying capital in strategic acquisitions. Given the favorable secular trends and growing need for value-based care, its efforts to strengthen its OM footprint will boost long-term growth.
WELL’s capital-recycling efforts highlight its prudent capital management practices and pave the way for long-term growth. From the beginning of the year through July 28, 2025, Welltower completed $3.96 billion of pro-rata gross investments, including $3.7 billion in acquisitions and loan funding, and $254.9 million in development funding. The company has also been disposing of assets simultaneously. From the beginning of the year through July 28, 2025, Welltower completed pro rata property dispositions of $408.9 million and loan repayments of $215.5 million.
Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of June 30, 2025, it had $9.5 billion of available liquidity, including $4.5 billion of cash & restricted cash and full capacity under its $5 billion line of credit. As of June 30, 2025, the net debt to adjusted EBITDA was 2.93X, improving from 3.68X year over year. Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.8 years, thereby enhancing its financial flexibility.
What’s Hurting Welltower?
Welltower faces competition from other healthcare companies such as Ventas VTR and Healthpeak Properties DOC regarding factors such as quality, price and the range of services provided. It also competes for reputation, location, and demographics of the population in the surrounding area and the financial condition of its tenants and operators. Such competition from companies like VTR and DOC is likely to limit the company’s power to significantly raise its top line and ink deals at attractive rates.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ventas, Inc. (VTR): Free Stock Analysis Report Healthpeak Properties, Inc. (DOC): Free Stock Analysis Report Welltower Inc. (WELL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research